Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 3/2009

01-01-2009 | Case Report

The development of dysphagia and dysphonia due to anterior cervical osteophytes

Authors: Ayla Akbal, Aydan Kurtaran, Barin Selcuk, Aysel Gurcan, Murat Ersoz, Mufit Akyuz

Published in: Rheumatology International | Issue 3/2009

Login to get access

Abstract

Cervical osteophytes may cause dysphagia by compressing the esophagus and may cause dysphonia by compressing the larynx and inferior laryngeal nerve. The occurrence of dysphagia and dysphonia due to cervical osteophytes has rarely been reported in literature. In this article, a case, in which the multiple cervical osteophytes were found to be the cause of dysphagia and dysphonia, was evaluated by imaging methods and electrophysiological evaluation of swallowing and the case was discussed in the light of relevant literatures.
Literature
1.
Di Vito J (1998) Cervical osteophytic dysphagia: single and combined mechanisms. Dysphagia. Winter 13(1):58–61
2.
Ozgocmen S, Kiris A, Kocakoc E, Ardicoglu O (2002) Osteophyte-induced dysphagia: report of three cases. Joint Bone Spine 69(2):226–229 MarPubMedCrossRef
3.
Selçuk B, Uysal H, Aydogdu I, Akyuz M, Ertekin C (2007) Effect of temperature on electrophysiological parameters of swallowing. J Rehabil Res Dev 44(3):373–380PubMedCrossRef
4.
Ertekin C, Pehlivan M, Aydoğdu I, Ertaş M, Uludağ B, Celebi G, Colakoğlu Z, Sağduyu A, Yüceyar N (1995) An electrophysiological investigation of deglutition in man. Muscle Nerve 18(10):1177–1186 OctPubMedCrossRef
5.
Ertekin C, Aydoğdu I, Yüceyar N (1996) Piecemeal deglutition and dysphagia limit in normal subjects and in patients with swallowing disorders. J Neurol Neurosurg Psychiatry 61(5):491–496 NovPubMedCrossRef
6.
Walther EK (1991) Vertebrogenic dysphagia in diffuse idiopathic skeletal hyperostosis(Forestier’disease). Laryngorbinootologie 70(11):604–608CrossRef
7.
Mosher HP (1926) Exostoses of the cervical vertebrae as a cause for diffuculty in swallowing. Laryngoscope 36:181–182CrossRef
8.
Saffouri MH, Ward PH (1974) Surgical correction of dysphagia due to cervical osteophytes. Ann Otol Rhinol Laryngol 83:65–70PubMed
9.
Strasser G, Schima W, Schober E, Pokieser P, Kaider A, Denk DM (2000) Cervical osteophytes impinging on the pharynx: importance of size and concurrent disorders for development of aspiration. AJR Am J Roentgenol 174:449–453PubMed
10.
Sobol SM, Rigual NR (1984) Anterolateral extrapharyngeal approach for cervical osteophyte-induced dysphagia. Literature review. Ann Otol Rhinol Laryngol 93:498–504PubMed
11.
Mc Cafferty RR, Harrison MJ, Tamas LB, Larkins MV (1995) Ossification of the anterior longituinal ligament and Farestier’s disease: An analysis of seven cases. J Neurusurgery 83:13–17CrossRef
12.
Valadka AB, Kubal WS, Smith MM (1995) Updated management strategy for patients with cervical osteophytic dysphagia. Dysphagia 10(3):167–171 SummerPubMedCrossRef
13.
Balmes C (1996) Clinical manifestations of diffuse idiopathic skeletal hyperostosis (DISH). Br J Rheumatol 35:1193–1196CrossRef
14.
Hirano H, Suzuki H, Sakakibara T, Higuchi Y, İnoue K, Suzuki Y (1982) Dysphagia due to hypertrophic cervical osteophytes. Clin Orthop 167:168–172PubMed
15.
Khtar S, O’flynn PE, Kelly A, Valentine PM (2000) The management of dysphasia in skeletal hyperostosis. J Laryngol Otol 114(2):154–157 Feb
Metadata
Title
The development of dysphagia and dysphonia due to anterior cervical osteophytes
Authors
Ayla Akbal
Aydan Kurtaran
Barin Selcuk
Aysel Gurcan
Murat Ersoz
Mufit Akyuz
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0669-6

Other articles of this Issue 3/2009

Rheumatology International 3/2009 Go to the issue

Original Paper

Circulating E-selectin and tumor necrosis factor-α in extraarticular involvement and joint disease activity in rheumatoid arthritis

Original Article

Normal levels and function of endothelial progenitor cells in patients with psoriatic arthritis

Case Report

Rapidly developed huge bursitis associated with scapular osteochondroma of the multiple exostosis: a case report

Original Article

A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China

Review

Clinical observations programme in SpA: disease parameters, treatment options and practical management issues

Case Report

Osteopoikilosis coexistent with ankylosing spondylitis and familial Mediterranean fever
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits